Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check4 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a minor revision to the page. It does not appear to alter core study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.4 to v3.6.5. This indicates a small documentation update rather than a substantive content change.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/template update that does not change the visible study details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2, indicating a new version of the referenced protocol/documentation. This is a technical update to the page's supporting materials and does not change the study details presented.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor release of the page template/backend rather than changes to the study details.SummaryDifference0.0%

- Check82 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', indicating enrollment is closed. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizes the Intervention/Treatment heading, and updates the revision label from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.